Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipman

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
BMJ Open Respiratory Research|June 23, 2020
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman, Joanne Cleverley, Tom Fardon, et al.
ERJ Open Research|December 24, 2025
Optimising non-pharmacological interventions in people with non-tuberculous mycobacterial pulmonary disease: a systematic reviewNaif Sulaiman, Beatriz Martins, Diana Moreira-Sousa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2022
Latent Tuberculosis Infection CareKatherine M Gaskell, Timesh D Pillay, James Brown, et al.
The European Respiratory Journal|June 27, 2015
Airway bacteria and respiratory symptoms are common in ambulatory HIV-positive UK adultsCamus Nimmo, Santino Capocci, Isobella Honeyborne, et al.
Annals of the American Thoracic Society|February 22, 2020
Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort StudyRishi K Gupta, Heinke Kunst, Marc Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2024
Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023Elena Ferran, Cathleen Chan, Noorann Sheikh, et al.
The European Respiratory Journal|October 2, 2013
Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?Veronica Melchionda, Harry Wyatt, Santino Capocci, et al.
The Journal of Infectious Diseases|September 11, 2019
Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based CohortAnthea L Katelaris, Charlotte Jackson, Jo Southern, et al.
Eclinicalmedicine|July 9, 2020
Enrichment of the airway microbiome in people living with HIV with potential pathogenic bacteria despite antiretroviral therapySylvia A D Rofael, James Brown, Elisha Pickett, et al.
The Journal of Infection|April 12, 2023
Impact of COVID-19 on NHS tuberculosis services: Results of a UK-wide surveyHazel Morrison, Felicity Perrin, Martin Dedicoat, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
BMJ Open Respiratory Research|June 23, 2020
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman, Joanne Cleverley, Tom Fardon, et al.
ERJ Open Research|December 24, 2025
Optimising non-pharmacological interventions in people with non-tuberculous mycobacterial pulmonary disease: a systematic reviewNaif Sulaiman, Beatriz Martins, Diana Moreira-Sousa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2022
Latent Tuberculosis Infection CareKatherine M Gaskell, Timesh D Pillay, James Brown, et al.
The European Respiratory Journal|June 27, 2015
Airway bacteria and respiratory symptoms are common in ambulatory HIV-positive UK adultsCamus Nimmo, Santino Capocci, Isobella Honeyborne, et al.
Annals of the American Thoracic Society|February 22, 2020
Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort StudyRishi K Gupta, Heinke Kunst, Marc Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2024
Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023Elena Ferran, Cathleen Chan, Noorann Sheikh, et al.
The European Respiratory Journal|October 2, 2013
Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?Veronica Melchionda, Harry Wyatt, Santino Capocci, et al.
The Journal of Infectious Diseases|September 11, 2019
Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based CohortAnthea L Katelaris, Charlotte Jackson, Jo Southern, et al.
Eclinicalmedicine|July 9, 2020
Enrichment of the airway microbiome in people living with HIV with potential pathogenic bacteria despite antiretroviral therapySylvia A D Rofael, James Brown, Elisha Pickett, et al.
The Journal of Infection|April 12, 2023
Impact of COVID-19 on NHS tuberculosis services: Results of a UK-wide surveyHazel Morrison, Felicity Perrin, Martin Dedicoat, et al.
Pageof 19